Work

Cediranib, an orally available and highly potent VEGFR signaling inhibitor, inhibits angiogenesis and progression and enhances the effects of paclitaxel in orthotopic human lung adenocarcinoma models

Year: 2007

Type: article

Source: Molecular Cancer Therapeutics

Authors: Kazuhisa Furutani, Ritsuko Komaki, Toshio Kuwai, Joerg J. Jacoby, Maria Korshunova, Baruch Erez, Anderson J. Ryan, Juliane M. Jürgensmeier, Roy S. Herbst, Michael S. O’Reilly

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2256729348

FWCI:

Cites:

Cited by:

Related to: 10